RAC 1.27% $1.55 race oncology ltd

Ann: Race Appoints George Clinical for Phase 1 Trial of RC220, page-118

  1. 58 Posts.
    lightbulb Created with Sketch. 32
    Mason, for cancer efficacy only (not cardio protection), based on the information you have to hand, what would be optimal dosing? I've always thought we would ideally administer low amounts (say 20mg/m2) twice weekly or something similar to this to ensure constant inhibition of FTO.

    I guess the upcoming trial where we measure the m6a levels will help guide future cancer efficacy trials.
 
watchlist Created with Sketch. Add RAC (ASX) to my watchlist
(20min delay)
Last
$1.55
Change
-0.020(1.27%)
Mkt cap ! $264.0M
Open High Low Value Volume
$1.59 $1.62 $1.51 $218.3K 138.7K

Buyers (Bids)

No. Vol. Price($)
1 95 $1.53
 

Sellers (Offers)

Price($) Vol. No.
$1.55 157 1
View Market Depth
Last trade - 16.10pm 16/08/2024 (20 minute delay) ?
RAC (ASX) Chart
arrow-down-2 Created with Sketch. arrow-down-2 Created with Sketch.